SHARE EXCHANGE AGREEMENTShare Exchange Agreement • October 23rd, 2020 • MedGen, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledOctober 23rd, 2020 Company Industry JurisdictionThis Share Exchange Agreement (this “Agreement”), dated as June 25, 2020, is by and among MedGen, Inc. a Wyoming corporation (the “Parent”), 9430075 Canada Ltd., a company incorporated in Manitoba, Canada (the “Company”), and each of the shareholders of the Company named herein as signatories (the “Shareholders”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties.”
SUBSCRIPTION AGREEMENTSubscription Agreement • October 23rd, 2020 • MedGen, Inc. • Pharmaceutical preparations • Wyoming
Contract Type FiledOctober 23rd, 2020 Company Industry JurisdictionMedGen, Inc., a Wyoming corporation (hereinafter the "Company"), and the undersigned (hereinafter the "Subscriber") agree as follows:
AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENTShare Exchange Agreement • October 23rd, 2020 • MedGen, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledOctober 23rd, 2020 Company Industry JurisdictionTHIS AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT (this "Amendment") is made as of September 16, 2020, by and among MedGen, Inc., a Wyoming corporation (the "Parent"), 9430075 Canada Ltd., a company incorporated in Manitoba, Canada (the “Company”), and each of the shareholders of the Company named herein as signatories (the “Shareholders”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties.”
NOTE SETTLEMENT AND DEBT RESTRUCTURE AGREEMENTNote Settlement and Debt Restructure Agreement • October 23rd, 2020 • MedGen, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledOctober 23rd, 2020 Company Industry JurisdictionThis NOTE SETTLEMENT AND DEBT RESTRUCTURE AGREEMENT (this “Agreement”) is made effective as of August 24, 2018 (the “Effective Date”) by and among Antevorta Capital Partners Limited (the “Note Holder”) and MedGen, Inc. (the “Company”).